Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Nuclear Regulatory Commission

This article was originally published in The Gray Sheet

Executive Summary

Nuclear Regulatory Commission: Advisory committee on the medical uses of isotopes is slated to meet April 10-11 in Rockville, Maryland to discuss the commission's staff requirements memorandum "Materials/Medical Oversight (DSI 7)"; its medical policy statement of 1979; criteria and ranking of medical procedures by risk; regulatory use of the advisory committee process; and status reports on proposed rulemaking and guidance documents." On April 11, the committee will also prepare for a May 15 meeting with the commissioners. For more information, contact NRC's William McCarthy at 301/415-7900...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007819

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel